Below is a list of publications from our team.


Norinder U, Svensson F (2019), Multi-task Modeling with Confidence using Matrix Factorization and Conformal Prediction. J. Chem. Inf. Mod. Accepted 25th March 2019. In press.

Newton TM, J. A. Duce JA, Bayle ED (2019). The proteostasis network provides targets for neurodegeneration. Brit. J. Pharm. Epub ahead of print, DOI:10.1111/bph.14643.

Magno M, Lessard CB, Martins M, Lang, V, Cruz P, Asi YT, Katan M, Bilsland J, Lashley T, Chakrabaty P, Golde TE, Whiting PJ (2019). Alzheimer’s disease Phospholipase C-gamma-2 (PLCG2) protective variant is a functional hypermorph. Alzheimer’s Research & Therapy 11(1):16.

Fish PV, Steadman, D, Bayle ED, Whiting PJ (2019). New Approaches for the Treatment of Alzheimer’s Disease. Bioorg. Med. Chem Lett. 29: 125-133.


Gibbs KL, Kalmar B, Rhymes ER, Fellows AD, Ahmed M, Whiting P, Davies CH, Greensmith L, Schiavo G (2018). Inhibiting p38 MAPK alpha rescues axonal retrograde transport defects in a mouse model of ALS. Cell Death Dis. 9:596-603.


Atkinson, BN, Woodward HL, Sipthorp, J, Fish PV (2017) Regioselective and enantiospecific synthesis of the HSP co-inducer arimoclomol from chiral glycidyl derivatives. Org. Biomol. Chem.15: 9794-9799.